JDRF Research

JDRF funds research that transforms the lives of people with type 1 diabetes (T1D). We want a cure, and we won’t stop until we find one.

[Breakthrough T1D @BreakthroughT1D]

BREAKING NEWS! A CDC advisory committee voted 14-0 recommending the use of the Pfizer/BioNTech COVID-19 vaccine in children ages 5-11. The CDC Director will soon make a recommendation on behalf of the CDC. Stay tuned for more details!

[JDRF Research @JDRFResearch]

Vertex VX-880 shows promising data from its Phase 1/2 Clinical Trial, including a 91% reduction in daily insulin requirement after 90 days. Learn more:

https://t.co/AEuWQiI93g

[JDRF Research @JDRFResearch]

JDRF mourns the loss of T1D researcher Stacey Anderson, M.D. Read about her many contributions to the T1D here: https://t.co/coOjmVZmai

[JDRF Research @JDRFResearch]

@JDRF is proud to announce the appointment of @ShereefElnahal to the JDRF Research Committee. Learn more here: https://t.co/mo89aXOSfw

[JDRF Research @JDRFResearch]

Last week, @JDRF and @NIDDKgov brought together the top minds in immunology, material science, bioengineering, transplants and more to discuss keeping transplanted beta cells healthy through immune tolerance and localized immune modulation.

Learn more: https://t.co/lnwuuLUl32

[JDRF Research @JDRFResearch]

Good news for the T1D community: @US_FDA has approved Semglee® as the first interchangeable biosimilar insulin product.

Learn more at the blog: https://t.co/JYgk474Qvj

[JDRF Research @JDRFResearch]

@JDRF is proud to have supported JDRF T1D Fund portfolio company Protomer Technologies since its inception and is thrilled to hear it has a new home at @LillyPad!

https://t.co/ryPIPAOADG

[Breakthrough T1D @BreakthroughT1D]

Dr. Nikki Farnsworth discusses her research around beta cell death and how she's working to identify potential targets to help prevent beta cell death. #JDRFxADA #ADA2021

[Breakthrough T1D @BreakthroughT1D]

Check out our recap of Day 1 of the @AmDiabetesAssn's Scientific Sessions at the link below! #JDRFxADA #ADA2021

https://t.co/QTHzBVfNlZ

[Breakthrough T1D @BreakthroughT1D]

Join us at 7pm ET for a Facebook Premiere event featuring key takeaways from Day 1 of The @AmDiabetesAssn's Scientific Sessions. Tune in at https://t.co/6Wdihd8G4g #JDRFxADA #ADA2021

[Breakthrough T1D @BreakthroughT1D]

Elad Sintov discusses his work focuses around building genetic modifications in stem cells as a replacement therapy for type 1 diabetes (T1D). #JDRFxADA #ADA2021

[Breakthrough T1D @BreakthroughT1D]

Adriana Migliorini discusses her work, which is focused around understanding immune cells and endocrine cells during human pancreatic development #JDRFxADA #ADA2021

[Breakthrough T1D @BreakthroughT1D]

JDRF's Vice President of Research, Dr. Sanjoy Dutta shares what you can expect to learn from The @AmDiabetesAssn's 81st annual Scientific Sessions and how we'll be keeping you updated. #JDRFxADA #ADA2021

[Breakthrough T1D @BreakthroughT1D]

At 1pm ET JDRF's Vice President of Research, Dr. Sanjoy Dutta will be giving a preview of what you can expect to learn from the @AmDiabetesAssn 81st Scientific Sessions, and how we'll be keeping you updated! #JDRFxADA #ADA2021

[Type 1 Diabetes TrialNet @T1D_TrialNet]

We are proud to announce that Kevan Herold, M.D., C.N.H., Long Professor of Immunobiology and professor of medicine at Yale University, has been named chair of Type 1 Diabetes TrialNet.

Congratulations, Dr. Herold!

https://t.co/Aa3dFptmVa

@NIDDKgov

[JDRF Research @JDRFResearch]

JDRF Vice President of Research, Sanjoy Dutta, Ph.D., congratulates Kevan Herald, M.D. on his appointment as the new TrialNet Chair. Read more:

https://t.co/1rqbdTRtF9

[Breakthrough T1D @BreakthroughT1D]

JDRF applauds the U.S. Food and Drug Administration’s (FDA) Advisory Committee positive recommendation in support of approval of teplizumab for those at risk for developing clinical T1D.

Learn more here: https://t.co/xiiOyOpOGY

[JDRF Research @JDRFResearch]

Life with T1D is tough. That's why JDRF is observing Mental Health Awareness Month and supporting psychosocial health issues in people with T1D through the JDRF Behavioral Health and Psychology Program.

Learn more at the blog: https://t.co/82yykQfkhR

[JDRF Research @JDRFResearch]

We also want to thank and celebrate everyone who has been in a clinical trial. You are heroes!

[JDRF Research @JDRFResearch]

May 20th is Clinical Trials Day! Today, we want to raise awareness about them and the pivotal role they play in bringing new therapies into the hands of the T1D community.

Learn more, including how to find a clinical trial, at the blog.

https://t.co/iIK00KPMGm